Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy

Optimization of current pain management strategies is necessary in order to reduce medication risks. Promoting patient and healthcare provider education on pain and pain medications is an essential step in reducing inadequate prescribing behaviors and adverse events. In an effort to raise awareness...

Full description

Bibliographic Details
Main Authors: Robert Taylor, Salma Lemtouni, Karen Weiss, Joseph V. Pergolizzi
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Current Gerontology and Geriatrics Research
Online Access:http://dx.doi.org/10.1155/2012/196159
id doaj-c7e727a0ee5e40a8be6d25494ba0b90a
record_format Article
spelling doaj-c7e727a0ee5e40a8be6d25494ba0b90a2020-11-24T23:04:14ZengHindawi LimitedCurrent Gerontology and Geriatrics Research1687-70631687-70712012-01-01201210.1155/2012/196159196159Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID TherapyRobert Taylor0Salma Lemtouni1Karen Weiss2Joseph V. Pergolizzi3NEMA Research Inc., 840-111th Avenue North Suite no. 9, Naples, FL 34108, USAFDA Safe Use Initiative, (SUI), CDER, FDA, 11093 New Hampshire Avenue, Silver Spring, MD 20993, USAFDA Safe Use Initiative, (SUI), CDER, FDA, 11093 New Hampshire Avenue, Silver Spring, MD 20993, USADepartment of Medicine, John Hopkins University School of Medicine, Baltimore, MD 21205, USAOptimization of current pain management strategies is necessary in order to reduce medication risks. Promoting patient and healthcare provider education on pain and pain medications is an essential step in reducing inadequate prescribing behaviors and adverse events. In an effort to raise awareness on medication safety, the FDA has launched the Safe Use Initiative program. The program seeks to identify areas with the greatest amount of preventable harm and help promote new methods and practices to reduce medication risks. Since the establishment of the program, FDA’s Safe Use initiative staff convened a panel of key opinion leaders throughout the medical community to address pain management in older adults (≥65 years of age). The aim of the expert panel was to focus on areas where significant risk occurs and where potential interventions will be feasible, implementable, and lead to substantial impact. The panel suggested one focus could be the use of NSAIDs for pain management in the elderly.http://dx.doi.org/10.1155/2012/196159
collection DOAJ
language English
format Article
sources DOAJ
author Robert Taylor
Salma Lemtouni
Karen Weiss
Joseph V. Pergolizzi
spellingShingle Robert Taylor
Salma Lemtouni
Karen Weiss
Joseph V. Pergolizzi
Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy
Current Gerontology and Geriatrics Research
author_facet Robert Taylor
Salma Lemtouni
Karen Weiss
Joseph V. Pergolizzi
author_sort Robert Taylor
title Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy
title_short Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy
title_full Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy
title_fullStr Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy
title_full_unstemmed Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy
title_sort pain management in the elderly: an fda safe use initiative expert panel’s view on preventable harm associated with nsaid therapy
publisher Hindawi Limited
series Current Gerontology and Geriatrics Research
issn 1687-7063
1687-7071
publishDate 2012-01-01
description Optimization of current pain management strategies is necessary in order to reduce medication risks. Promoting patient and healthcare provider education on pain and pain medications is an essential step in reducing inadequate prescribing behaviors and adverse events. In an effort to raise awareness on medication safety, the FDA has launched the Safe Use Initiative program. The program seeks to identify areas with the greatest amount of preventable harm and help promote new methods and practices to reduce medication risks. Since the establishment of the program, FDA’s Safe Use initiative staff convened a panel of key opinion leaders throughout the medical community to address pain management in older adults (≥65 years of age). The aim of the expert panel was to focus on areas where significant risk occurs and where potential interventions will be feasible, implementable, and lead to substantial impact. The panel suggested one focus could be the use of NSAIDs for pain management in the elderly.
url http://dx.doi.org/10.1155/2012/196159
work_keys_str_mv AT roberttaylor painmanagementintheelderlyanfdasafeuseinitiativeexpertpanelsviewonpreventableharmassociatedwithnsaidtherapy
AT salmalemtouni painmanagementintheelderlyanfdasafeuseinitiativeexpertpanelsviewonpreventableharmassociatedwithnsaidtherapy
AT karenweiss painmanagementintheelderlyanfdasafeuseinitiativeexpertpanelsviewonpreventableharmassociatedwithnsaidtherapy
AT josephvpergolizzi painmanagementintheelderlyanfdasafeuseinitiativeexpertpanelsviewonpreventableharmassociatedwithnsaidtherapy
_version_ 1725631748511891456